Literature DB >> 10971425

Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma.

A Weimann1, H Varnholt, H J Schlitt, H Lang, P Flemming, C Hustedt, G Tusch, R Raab.   

Abstract

BACKGROUND: Cholangiocellular carcinoma is an uncommon primary liver cancer, which may be mixed with hepatocellular carcinoma. A retrospective analysis was undertaken to evaluate the results of surgical treatment and to identify prognostic factors.
METHODS: Between 1978 and 1996, 162 patients underwent surgery for cholangiocellular carcinoma: liver resection (n = 95), liver transplantation (n = 24) and exploratory laparotomy with and without drainage (n = 43). Univariate and multivariate analyses of prognostic factors were performed.
RESULTS: Overall survival was 47 per cent at 1 year, 28 per cent at 2 years and 13 per cent at 5 years. Survival rates for patients with resectable tumours were 64, 43 and 21 per cent respectively, and for those who underwent liver transplantation 21, 8 per cent and zero respectively. Univariate analysis showed that the following variables had an effect on survival: age, jaundice, liver resection, T, N and M stage in the tumour node metastasis classification, Union Internacional Contra la Cancrum (UICC) tumour stage, tumour-free margins, vascular infiltration, tumour number, tumour size and serum level of carcinoembryonic antigen. Multivariate analysis identified jaundice, N and M category, and UICC tumour stage as independent prognostic factors.
CONCLUSION: The data underscore the importance and prognostic value of the UICC tumour classification for cholangiocellular carcinoma. The prognosis of mixed tumours is no different. Liver resection remains the treatment of choice; transplantation offers no solution for otherwise unresectable tumours.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971425     DOI: 10.1046/j.1365-2168.2000.01532.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  28 in total

Review 1.  Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.

Authors:  Boris Blechacz; Gregory J Gores
Journal:  Hepatology       Date:  2008-07       Impact factor: 17.425

2.  Survival outcomes and prognostic factors of surgical therapy for all potentially resectable intrahepatic cholangiocarcinoma: a large single-center cohort study.

Authors:  Xianwu Luo; Lei Yuan; Yi Wang; Ruiliang Ge; Yanfu Sun; Gongtian Wei
Journal:  J Gastrointest Surg       Date:  2014-01-07       Impact factor: 3.452

3.  Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma.

Authors:  Wei-Feng Shen; Wei Zhong; Feng Xu; Tong Kan; Li Geng; Feng Xie; Cheng-Jun Sui; Jia-Mei Yang
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

4.  The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.

Authors:  Qing Chen; Liu-Xiao Yang; Xue-Dong Li; Dan Yin; Shi-Ming Shi; Er-Bao Chen; Lei Yu; Zheng-Jun Zhou; Shao-Lai Zhou; Ying-Hong Shi; Jia Fan; Jian Zhou; Zhi Dai
Journal:  Tumour Biol       Date:  2015-02-12

Review 5.  [Liver resection and transplantation for hepatic tumors].

Authors:  H Lang; C E Broelsch
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

Review 6.  Liver transplantation for cholangiocarcinoma: Current status and new insights.

Authors:  Gonzalo Sapisochín; Elena Fernández de Sevilla; Juan Echeverri; Ramón Charco
Journal:  World J Hepatol       Date:  2015-10-08

Review 7.  Surgical management of proximal bile duct cancers.

Authors:  Jennifer LaFemina; William R Jarnagin
Journal:  Langenbecks Arch Surg       Date:  2012-03-06       Impact factor: 3.445

8.  Superiority of combined chemo-embolization and portal infusion with 5-fluorouracil over locoregional infusion concepts in Novikoff hepatoma-bearing rats.

Authors:  Hermann Bödeker; Ernst-Jan Kamphorst; Peter H Wünsch; Ulrich Linnemann; Martin R Berger
Journal:  J Cancer Res Clin Oncol       Date:  2003-09-26       Impact factor: 4.553

9.  Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections.

Authors:  Elie Chouillard; Daniel Cherqui; Claude Tayar; Francesco Brunetti; Pierre-Louis Fagniez
Journal:  Ann Surg       Date:  2003-07       Impact factor: 12.969

10.  A genetic database can be utilized to identify potential biomarkers for biphenotypic hepatocellular carcinoma-cholangiocarcinoma.

Authors:  Shaffer R S Mok; Sachin Mohan; Navjot Grewal; Adam B Elfant; Thomas A Judge
Journal:  J Gastrointest Oncol       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.